Oral Fluid / Saliva Drug Screening
Oral Fluid drug screening can be administered via two methods, instant ‘point of care’ or via Laboratory analysis. The screening stage provides initial results which determine if substances are present in a person’s sample or not, either ‘non-negative’ or ‘negative’.
Saliva / Oral Fluid drug screening offers the following advantages:
- Two screening methods, instant ‘point of care’ or Laboratory
- Non-invasive collection
- No requirement for secure toilet facility
- A shorter detection window
- Fully accredited Laboratory Confirmation
A range of drugs can be detected:
- Barbiturates (BAR)
- Benzodiazepine (BZO)(including Diazepam, Temazepam and others)
- Cannabis (THC)
- Cocaine (COC)
- Ecstasy (MDMA)
- Heroin (within OPI test)
- Methadone (MTD)
- Methamphetamine (MAMP)
- Opiates (OPI)(including Morphine, Dihydrocodeine and others)
Following initial collection preparations, donors are legally identified and their samples collected using a strict set of procedures called ‘the chain of custody’. The sample is then either screened straight away using a point of care device or packaged with the appropriate security protocols to ensure the integrity of the sample and screened at the Laboratory. If either method presents a ‘non negative’ result, the sample enters the Confirmation stage which involves more in depth scientific analysis. At this point, it can be determined whether the substance found if medication in line with a therapeutic dose or illegal substance(s).
Why use Racoo Screening?
Racoo Screening has 16 years’ experience in assisting companies and other organisations with the development and management of their drug and alcohol programme, including their drug and alcohol misuse policy.
Whether you are a small business, large international corporate or public sector organisation, Racoo Screening can help with your individual requirements offering a professional, personal and flexible implementation and advice service.